Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells

Arthritis and Rheumatism

Volumn 40, Issue 11, 1997, Pages 2030-2038

  De Bandt, Michel ^a   Ollivier, Véronique ^b   Meyer, Olivier ^a   Babin Chevaye, Catherine ^b   Khechaï, Fouzi ^b   De Prost, Dominique ^b   Hakim, Jacques ^b   Pasquier, Catherine ^b  

^a CENTRE HOSPITALIER   (France)

^b EMI 0112 Faculte de Medecine Bichat   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; MESSENGER RNA; NEUTROPHIL CYTOPLASMIC ANTIBODY; THROMBOPLASTIN;

ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; THROMBOSIS; VASCULAR ENDOTHELIUM; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; ENDOTHELIUM, VASCULAR; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-1; MYELOBLASTIN; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; SERINE ENDOPEPTIDASES; THROMBOPLASTIN; UMBILICAL VEINS; WEGENER GRANULOMATOSIS;

EID: 0030833084     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401116     Document Type: Article

References (48)

1. Jennings JHG, Chang L, Savige JA: Anti-proteinase 3 antibodies, their characterization and disease associations. Clin Exp Immunol 95:251-256, 1994
2. Gross WL, Csernok E, Flesch B: Classic anti-neutrophil cytoplasmic antibodies (C-ANCA), Wegener's autoantigen and their immunopathogenic role in Wegener's granulomatosis. J Autoimmun 6:171-184, 1993
3. Rao LK, Feussner JR, Weinberg M: A prospective study of antineutrophil cytoplasmic antibody (C-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 346:926-931, 1995
4. Tomer Y, Gilburd B, Blank M, Lider O, Hershkoviz R, Fishman P, Zigelman R, Meroni PL, Wiik A, Shoenfeld Y: Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Arthritis Rheum 38:1375-1381, 1995
5. Gross WL, Csernok E: Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 7:11-19, 1995
6. Kallenberg CGM, Brouwer E, Mulder HL, Stegeman CA, Weening JJ, Cohen Tervaert JW: ANCA pathophysiology revisited. Clin Exp Immunol 100:1-3, 1995
7. Jennette JC, Falk RJ, Terrel RS, Charles LA: Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115-4119, 1990
8. Porgess A, Recheda PB, Kimberly WT, Csernok E, Groos WL, Kimberly RP: ANCA engage and activate human neutrophils via Fey receptor R II. J Immunol 153:1271-1280, 1994
9. Ewert B, Jennette CH, Falk RJ: Anti-myeloperoxidase antibodies stimulate the neutrophils to damage endothelial cells. Kidney Int 41:375-383, 1992
10. Ames PR, Roes LA, Lupoll S, Pickering M, Brancaccio V, Khamashta M, Hughes RGV: Thrombosis in Churg-Strauss syndrome, beyond vasculitis? Br J Rheumatol 35:1181-1183, 1996
11. Lie JT: Histopathologic specificity of systemic vasculitis. Rheum Dis Clin North Am 21:883-909, 1995
12. Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman LM, Dalmasso AP, Platt JL: The immunopathology of cardiac xenograph rejection in the guinea pig to rat model. Transplantation 56:1-8, 1993
13. Arthus M: Injections répétées de serum de cheval chez le lapin. C R Seances Soc Biol Fil 55:817-820, 1903
14. Cochrane CG, Weigle WO, Dixon JF: The role of polymorphonuclear leukocytes in the initiation and cessation of Arthus vasculitis. J Exp Med 110:481-501, 1959
15. Lau CS, McLaren M, Hanslip J, Kerr M, Belch JF: Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolysis response in those complicated by vasculitis. Ann Rheum Dis 52:643-647, 1993
16. Boehme M, Schmitt W, Youinou P, Stremmel W, Gross W: Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am J Med 101:387-394, 1996
17. Nusinow SR, Federici AB, Zimmerman TS, Curd JG: Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 27:1405-1410, 1984
18. Blann AD: von Willebrand factor as a marker of injury to the endothelium in inflammatory vascular disease. J Rheumatol 20: 1469-1471, 1993
19. Sixma JJ, De Groot PG: von Willebrand factor and the blood vessel wall. Mayo Clin Proc 66:628-633, 1991
20. Mayet WJ, Meyer Zum Buschenfeld KH: Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 94:440-446, 1993
21. Mayet WJ, Schwarting A, Orth T, Meyer Zum Büschenfeld KH: Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin Exp Immunol 103:259-267, 1996
22. De Bandt M, Meyer O, Hakim J, Pasquier C: Antibodies to proteinase-3 mediate expression of intercellular adhesion molecule-1. Br J Rheumatol 36:839-846, 1997
23. Mayet WJ, Csernok E, Szymkoviak C, Gross WL, Meyer Zum Buschenfeld KH: Human endothelial cells express proteinase 3, the target of anticytoplasmic antibodies in Wegener granulomatosis. Blood 82:1221-1223, 1993
24. King WJ, Adu D, Daha MR, Brooks CJ, Radford DJ, Pall AA, Savage COS: Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 102:98-105, 1995
25. Mackman N: Regulation of the tissue factor gene. FASEB J 9:883-889, 1995
26. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 33:1101-1107, 1990
27. Wiik A, Rasmussen N, Wieslander J: Methods to detect autoantibodies to neutrophilic granulocytes. In, Manual of Biological Markers of Diseases. Edited by WJ van Venrooij, RN Maini. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1993
28. Sellak H, Franzini E, Hakim J, Pasquier C: Reactive oxygen species rapidly increase endothelium ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 83:2669-2677, 1994
29. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2751, 1973
30. 2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. J Clin Invest 79:600-608, 1987
31. Carson MD: Computerized analysis of enzyme cascade reactions using continuous rate data obtained with ELISA reader. Comput Methods Programs Biomed 19:151-155, 1985
32. Ternisien C, Ramani M, Ollivier V, Khechai F, Hakim J, de Prost D: Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation. Thromb Haemost 70:800-806, 1993
33. Bartha K, Brisson C, Archipoff G, de La Salle C, Lanza R, Cazenave J, Beretz A: Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem 8:421-426, 1993
34. Ferrua B, Becker P, Schaffar L, Shaw A, Fehlman M: Detection of human IL-1α and IL-1β at the subpicomolar level by colorimetric sandwich enzyme immunoassay. J Immunol Methods 114:41-47, 1988
35. Meyer O, Kaiser P, Haim T, Edgell CJ, Pasquier C, de Bandt M, Bridey F, Sellak H, Lansaman J, Kahn MF: Antivascular endothelial cell antibodies (AECA): comparison of two assay methods and clinical applications. Rev Rhum Engl Ed 11:737-743, 1995
36. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182:1807-1814, 1995
37. Carvalho D, Savage COS, Black C, Pearson JD: IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 97:111-119, 1996
38. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, Balcstrieri G, Radice A, Sinico RA, Meroni PL: Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 39:758-766, 1996
39. Roux-Lombard P, Lin HC, Peter JB, Dayer JM: Elevated serum level of TNFα soluble receptors in patients with positive ANCA. Br J Rheumatol 33:428-431, 1994
40. Carlsen E, Flatmark A, Prydz H: Cytokine-induced procoagulant activity in monocytes and endothelial cells: further enhancement by cyclosporine. Transplantation 46:575-580, 1988
41. Contrino J, Hair G, Kreutzer DL, Rickles FR: In situ detection of tissue factor in vascular endothelial cells: correlation with the phenotype of human breast disease. Nat Med 2:209-215, 1996
42. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
43. Golino P, Ragni M, Cirillo P, Avvedimento E, Feliciello A, Esposito N, Scognamiglio A, Trimarco B, Condorelli M, Chiariello M, Ambrosio G: Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2:35-40, 1996
44. Carlos TM, Harlan JM: Leukocytes-endothelial adhesion molecules. Blood 84:2068-2093, 1994
45. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNFα, II-1β and IL-2R in ANCA positive glomerulonephritis. Kidney Int 43:682-693, 1993
46. Brouwer E, Huitema MG, Mulder LH, Kallenberg CGM: Neutrophil activation in vitro and in vivo in Wegener granulomatosis. Kidney Int 45:1120-1131, 1994
47. Casselman BL, Kilgore KS, Miller BF, Warren JS: Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 126:495-502, 1995
48. De Prost D: Pentoxyfilline: a potential treatment for thrombosis associated with abnormal tissue factor expression by monocytes and endothelial cells. J Cardiovasc Pharmacol 25 (suppl 2):114-118, 1995